Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

• Hepatitis A Vaccine (Human Diploid Cell), Inactivated – Healive® Launched in 2002

Hepatitis A & Hepatitis B Combined Vaccine – Bilive®
Launched in 2005

Healive® is:
Prequalified by the World Health Organization.
Provides susta...

Influenza Vaccine (Split Virion), lnactivated – Anflu®
Pandemic Influenza Vaccine, lnactivated, Adjuvanted – Panflu®
H1N1 Influenza A Vaccine (Split Virion), lnactivated – Panflu.1®
Influenza Vaccine (Split Virion), lnactivated, Quadrivalent – TetrAnflu®

Anflu®, preservative-free ...

Zamerovimab and Mazorelvimab Injection (SYN023) is the World’s First Humanized mAb Cocktail against Rabies. It has approved in China since 2024. 

Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it has been named the exclusive strategic partner of BogotáBio, which will break ground as the first local human vaccine production facility to be established in Colombia’s capital city of Bogota.

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.